Cambridge Investment Research Advisors
NTUS

Cambridge Investment Research Advisors’s Natus Medical Inc NTUS Stock Holding History

Cambridge Investment Research Advisors’s Portfolio NTUS Stock Details NTUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-9,950
Closed -$224K – 1354
2013
Q4 		$224K Buy
+9,950
New +$192K 0.01% 1020

Other funds holding NTUS

EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CCM
Corsair Capital Management New York $673M AUM 109.99% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Diamond Hill Capital Management
Diamond Hill Capital Management Columbus, Ohio $12.5B AUM 7.49% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

Cambridge Investment Research Advisors's NTUS Position: Q1 2014 in Review

Cambridge Investment Research Advisors sold out of Natus Medical Inc (NTUS) in Q1 2014, closing a stake of 9,950 shares — an estimated $224K sold.

Cambridge Investment Research Advisors first reported a position in NTUS in Q4 2013 and held it in 1 quarter. The position peaked at $224K in Q4 2013. 181 funds tracked by Wall St. Rank hold NTUS as of Q1 2014.

  • Cambridge Investment Research Advisors reported no remaining Natus Medical Inc position as of Q1 2014 after selling out during the quarter.
  • Cambridge Investment Research Advisors sold 9,950 Natus Medical Inc shares in Q1 2014, an estimated $224K.
  • Cambridge Investment Research Advisors first reported a position in Natus Medical Inc in Q4 2013 and held it in 1 quarter.
  • Cambridge Investment Research Advisors's Natus Medical Inc position peaked at $224K in Q4 2013.
  • 181 funds tracked by Wall St. Rank held Natus Medical Inc as of Q1 2014.

Based on Cambridge Investment Research Advisors's 13F filing for Q1 2014, filed 29 Apr 2014.